Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Bioxis Pharmaceuticals
company
About
France-based developer of Monophasic Tissular inductor MTI12
- 11 - 50
Highlights
Details
- Last Funding Type
- Convertable Note
- Industries
- Biotechnology,Commercial,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
The company, which is certified ISO 13485, has 10 employees, including senior management with extensive experience from major players in aesthetic dermatology. It has received the support from Medicen, the life sciences cluster of the Paris Region (EIP label) as well as BPI France (French public investment bank).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
—
Bioxis Pharmaceuticals has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Apr 1, 2014 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 1, 2014 | Convertable Note | — | 1 | — | — | Detail |
| Jan 1, 2013 | Convertable Note | — | 1 | — | — | Detail |
| Aug 1, 2012 | Private Equity（PE） | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Bioxis Pharmaceuticals is funded by 1 investors.
Waarde Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Waarde Capital
|
— | Convertable Note |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
